Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biotech Gwth (BIOG) Share Price

Price 1,314.00p on 22-05-2026 at 18:35:11
Change 26.00p 2.02%
Buy 1,314.00p
Sell 1,302.00p
Last Trade: Unknown 60,000.00 at 1,285.11p
Day's Volume: 108,010
Last Close: 1,314.00p
Open: 1,294.00p
ISIN: GB0000385517
Day's Range 1,294.00p - 1,322.00p
52wk Range: 702.00p - 1,374.00p
Market Capitalisation: £256.74m
VWAP: 1,295.52992p
Shares in Issue: 19.54m

Biotech Gwth (BIOG) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 60,000 1,285.11p Negotiated Trade
16:40:43 - 22-May-26
Buy* 16,561 1,314.00p Suspected BUY Trade
16:35:20 - 22-May-26
Buy* 2 1,312.00p Automatic Execution
16:29:24 - 22-May-26
Buy* 29 1,312.00p Automatic Execution
16:26:49 - 22-May-26
Buy* 68 1,310.00p Automatic Execution
16:26:34 - 22-May-26
Sell* 53 1,310.00p Automatic Execution
16:25:24 - 22-May-26
Buy* 62 1,316.00p Automatic Execution
16:25:24 - 22-May-26
Buy* 62 1,314.00p Automatic Execution
16:25:23 - 22-May-26
Buy* 61 1,312.00p Automatic Execution
16:25:12 - 22-May-26
Buy* 58 1,314.00p Automatic Execution
16:25:01 - 22-May-26
See more Biotech Gwth trades

Biotech Gwth (BIOG) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd May 2026 (Fri) 1,294.00 1,322.00 1,294.00 1,314.00 108,010
21st May 2026 (Thu) 1,252.00 1,300.00 1,252.00 1,288.00 37,409
20th May 2026 (Wed) 1,244.00 1,284.00 1,244.00 1,260.00 43,952
19th May 2026 (Tue) 1,284.00 1,284.00 1,244.00 1,260.00 60,504
18th May 2026 (Mon) 1,312.00 1,316.00 1,272.00 1,280.00 92,090
15th May 2026 (Fri) 1,348.00 1,366.00 1,324.00 1,324.00 37,537
14th May 2026 (Thu) 1,360.00 1,374.00 1,344.00 1,352.00 46,131
13th May 2026 (Wed) 1,344.00 1,362.00 1,344.00 1,358.00 42,364
12th May 2026 (Tue) 1,320.00 1,346.00 1,318.00 1,346.00 33,234
11th May 2026 (Mon) 1,338.00 1,350.00 1,338.00 1,350.00 36,997
8th May 2026 (Fri) 1,332.00 1,338.00 1,318.00 1,324.00 79,530
7th May 2026 (Thu) 1,354.00 1,356.00 1,330.00 1,330.00 29,010
6th May 2026 (Wed) 1,340.00 1,344.00 1,324.00 1,344.00 33,276
5th May 2026 (Tue) 1,250.00 1,356.00 1,250.00 1,336.00 55,388
4th May 2026 (Mon) 1,304.00 1,304.00 1,304.00 1,304.00 0
1st May 2026 (Fri) 1,280.00 1,304.00 1,280.00 1,304.00 67,422
30th Apr 2026 (Thu) 1,274.00 1,276.00 1,256.00 1,270.00 35,650
29th Apr 2026 (Wed) 1,276.00 1,280.00 1,260.00 1,274.00 47,390
28th Apr 2026 (Tue) 1,290.00 1,296.00 1,272.00 1,278.00 35,102
27th Apr 2026 (Mon) 1,298.00 1,310.00 1,298.00 1,298.00 31,909
24th Apr 2026 (Fri) 1,308.00 1,310.00 1,280.00 1,280.00 44,477
See more Biotech Gwth price history

Biotech Gwth (BIOG) Regulatory News

Date Source Headline
22nd May 2026 5:19 pm PRN Transaction in Own Shares
22nd May 2026 1:30 pm PRN Net Asset Value(s)
21st May 2026 1:47 pm PRN Net Asset Value(s)
20th May 2026 1:07 pm PRN Net Asset Value(s)
19th May 2026 3:56 pm PRN Net Asset Value(s)
18th May 2026 2:33 pm PRN Net Asset Value(s)
15th May 2026 5:30 pm PRN Transaction in Own Shares
15th May 2026 3:00 pm PRN Net Asset Value(s)
14th May 2026 5:16 pm PRN Monthly Fact Sheet as at 30 April 2026
14th May 2026 1:02 pm PRN Net Asset Value(s)
See more Biotech Gwth regulatory news

Biotech Gwth (BIOG) Share News

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

UK shareholder meetings calendar - next 7 days

5th Nov 2025 14:25

Read More

Biotech Growth Trust appoints former UKHSA head Jenny Harries to board

17th Sep 2025 13:24

(Alliance News) - Biotech Growth Trust PLC on Wednesday said Jenny Harries has been appointed an independent non-executive director, as of Tuesday. Read More

IN BRIEF: Biotech Growth Trust says court confirms capital reduction

20th Aug 2025 15:09

Biotech Growth Trust PLC - biotechnology-focused investor - Says capital reduction to become effective upon the registration of a court order from the High Court at Companies House. The firm says the purpose of the capital reduction is to provide a "significant pool of reserves" which can be used in future to fund share buybacks or other returns of capital. "The cancellation will therefore provide the company with more flexibility in how capital may be returned in the future," the company says. Read More

IN BRIEF: Biotech Growth Trust director buys GBP75,000 in shares

4th Jun 2025 15:49

Biotech Growth Trust PLC - biotechnology-focused investor - Non-Executive Director Roger Yates buys 10,000 shares at 747.36 pence each, worth GBP74,736, on Wednesday. Earlier on Wednesday, the company said its net asset value declined during its most recent financial year, as market volatility weighs on investor appetite. Net asset value per share at March 31 was 815.9 pence, down 24% from 1,078.9p a year before. NAV total return for the year that ended March 31 was negative 24%, compared to a negative 6.0% return on its benchmark index, the Nasdaq Biotechnology Index. Read More

See more Biotech Gwth news
FTSE 100 Latest
Value10,466.26
Change22.79

Login to your account

Forgot Password?

Not Registered